Literature DB >> 18248619

The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices.

Erin L Meyer1, Doju Yoshikami, J Michael McIntosh.   

Abstract

Striatal dopamine (DA) plays a major role in the regulation of motor coordination and in the processing of salient information. We used voltammetry to monitor DA-release evoked by electrical stimulation in striatal slices, where interneurons continuously release acetylcholine. Use of the alpha6-selective antagonist alpha-conotoxin MII[E11A] and alpha4 knockout mice enabled identification of two populations of DA-ergic fibers. The first population had a low action potential threshold, and action potential-evoked DA-release from these fibers was modulated by alpha6. The second population had a higher action potential threshold, and only alpha4(non-alpha6) modulated action potential-evoked DA-release. Striatal DA-ergic neurons fire in both tonic and phasic patterns. When stimuli were applied in a train to mimic phasic firing, more DA-release was observed in alpha4 knockout versus wild-type mice. Furthermore, block of alpha4(non-alpha6), but not of alpha6, increased DA release evoked by a train. These results indicate that there are different classes of striatal DA-ergic fibers that express different subtypes of nicotinic receptors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18248619      PMCID: PMC2527994          DOI: 10.1111/j.1471-4159.2008.05266.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  57 in total

Review 1.  Getting past the asterisk: the subunit composition of presynaptic nicotinic receptors that modulate striatal dopamine release.

Authors:  Charles W Luetje
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

2.  Neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes have a pentameric quaternary structure.

Authors:  R Anand; W G Conroy; R Schoepfer; P Whiting; J Lindstrom
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

3.  Pentameric structure and subunit stoichiometry of a neuronal nicotinic acetylcholine receptor.

Authors:  E Cooper; S Couturier; M Ballivet
Journal:  Nature       Date:  1991-03-21       Impact factor: 49.962

4.  Electrophysiological and pharmacological evidence for the existence of distinct subpopulations of nigrostriatal dopaminergic neuron in the rat.

Authors:  P D Shepard; D C German
Journal:  Neuroscience       Date:  1988-11       Impact factor: 3.590

5.  The neostriatal mosaic: II. Patch- and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems.

Authors:  C R Gerfen; M Herkenham; J Thibault
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

6.  Responses of midbrain dopamine neurons to behavioral trigger stimuli in the monkey.

Authors:  W Schultz
Journal:  J Neurophysiol       Date:  1986-11       Impact factor: 2.714

7.  Nicotine amplifies reward-related dopamine signals in striatum.

Authors:  Margaret E Rice; Stephanie J Cragg
Journal:  Nat Neurosci       Date:  2004-05-16       Impact factor: 24.884

8.  Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin.

Authors:  P B Clarke; R D Schwartz; S M Paul; C B Pert; A Pert
Journal:  J Neurosci       Date:  1985-05       Impact factor: 6.167

9.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

10.  The neostriatal mosaic: III. Biochemical and developmental dissociation of patch-matrix mesostriatal systems.

Authors:  C R Gerfen; K G Baimbridge; J Thibault
Journal:  J Neurosci       Date:  1987-12       Impact factor: 6.167

View more
  40 in total

1.  Modulation of gain-of-function α6*-nicotinic acetylcholine receptor by β3 subunits.

Authors:  Bhagirathi Dash; Ronald J Lukas
Journal:  J Biol Chem       Date:  2012-02-07       Impact factor: 5.157

Review 2.  α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.

Authors:  Maryka Quik; Susan Wonnacott
Journal:  Pharmacol Rev       Date:  2011-12       Impact factor: 25.468

3.  α6ß2* and α4ß2* nicotinic receptors both regulate dopamine signaling with increased nigrostriatal damage: relevance to Parkinson's disease.

Authors:  Xiomara A Perez; Tanuja Bordia; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2010-08-23       Impact factor: 4.436

Review 4.  Targeting nicotinic receptors for Parkinson's disease therapy.

Authors:  Maryka Quik; Tanuja Bordia; Luping Huang; Xiomara Perez
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-09-01       Impact factor: 4.388

5.  Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.

Authors:  Michelle G Baladi; Shannon M Nielsen; J Michael McIntosh; Glen R Hanson; Annette E Fleckenstein
Journal:  Behav Pharmacol       Date:  2016-08       Impact factor: 2.293

6.  Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens.

Authors:  Xiomara A Perez; J Michael McIntosh; Maryka Quik
Journal:  J Neurochem       Date:  2013-10-13       Impact factor: 5.372

7.  Focus on α4β2* and α6β2* nAChRs for Parkinson's Disease Therapeutics.

Authors:  Xiomara A Pérez; Maryka Quik
Journal:  Mol Cell Pharmacol       Date:  2011

8.  Prominent role of alpha3/alpha6beta2* nAChRs in regulating evoked dopamine release in primate putamen: effect of long-term nicotine treatment.

Authors:  Xiomara A Perez; Kathryn T O'Leary; Neeraja Parameswaran; J Michael McIntosh; Maryka Quik
Journal:  Mol Pharmacol       Date:  2009-01-14       Impact factor: 4.436

9.  Born to Lead? A Twin Design and Genetic Association Study of Leadership Role Occupancy.

Authors:  Jan-Emmanuel De Neve; Slava Mikhaylov; Christopher T Dawes; Nicholas A Christakis; James H Fowler
Journal:  Leadersh Q       Date:  2012-09-10

Review 10.  Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors.

Authors:  Layla Azam; J Michael McIntosh
Journal:  Acta Pharmacol Sin       Date:  2009-05-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.